We are reproductive biologists, tissue engineers, computational biologists, and clinicians, united by a single goal: to explain early pregnancy loss and enable more targeted protocols and therapies for implantation failure and miscarriage.
Hugo Villanueva
CEO & Co-founder
Bioengineer by training. Second time founder, ex-BD director in cell and gene therapy and ex-VC.
Irene Aspalter
Head of Biology
15 years of building cutting edge vascularisation models and organ on chip in the Crick Institute.
Maria Ubach Vidal
Reproductive Biologist
Developed protocols for building vascularised implantation platforms in Cambridge University.
Advisors
Sarah Meyohas
Advisor & Co-founder
Frontier deeptech and biotech investor. GP at Bluebirds Capital and conceptual artist.